Search Result "cirrhotic hepatitis C virus"
Treatment of Hepatitis C Cirrhotic Patients With Directly Acting Antivirals: A Multicenter Study
Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 5 Year: 2021 Page: 15-21
Author(s): Asem Ahmed Elfert,Sherief Abd-Elsalam,Lobna Abo-Ali,Taher Eldemerdash,Sabry Abou-Saif,Hala Mostafa Elsabagh,Abla Ebeid,Rehab Badawi
Predicting Esophageal Varices in Cirrhotic Hepatitis C Virus Patients Using Noninvasive Measurement of Insulin Resistance Variables
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 18 Issue: 6 Year: 2018 Page: 579-586
Author(s): Elsaid Wasfy,Galal Elkassas,Sally Elnawasany,Kariman Elkasrawy,Sherief Abd-Elsalam,Shaimaa Soliman,Rehab Badawi
Sofosbuvir, Pegylated Interferon and Ribavirin in the Treatment of an Egyptian Cohort with Hepatitis C Virus Infection in Real-Life Clinical Practice
Journal: Infectious Disorders - Drug Targets
Volume: 19 Issue: 2 Year: 2019 Page: 179-184
Author(s): Sherief Abd-Elsalam,Rehab Badawi,Sally Elnawasany,Mohamed Yousef,Loai Mansour,Nehad Hawash,Reham A. Elkhouly,Shaimaa Soliman,Amal Selim,Abdelrahman Kobtan,Asem Elfert
Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15 Issue: 7 Year: 2015 Page: 553-581
Author(s): Zhuangzhuang Yu,Liwen Zhao,Qi-Dong You
Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues
Journal: Current Drug Targets
Volume: 18 Issue: 7 Year: 2017 Page: 851-862
Author(s): Jordan J. Feld
A New Potent NS5A Inhibitor in the Management of Hepatitis C Virus: Ravidasvir
Journal: Current Drug Discovery Technologies
Volume: 15 Issue: 1 Year: 2018 Page: 24-31
Author(s): Enas Hafez,Tamer Elbaz,Mohamed El Kassas,Gamal Esmat
Current and Future Therapy for Chronic Hepatitis C Virus Liver Disease
Journal: Current Drug Targets - Infectious Disorders
Volume: 3 Issue: 3 Year: 2003 Page: 247-253
Author(s): G. Lake-Bakaar
Hepatitis C Viruss Immune Evasion Strategies
Journal: Current Immunology Reviews
Volume: 1 Issue: 3 Year: 2005 Page: 223-235
Author(s): Michael W. Cruise, John R. Lukens, Young S. Hahn
Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection
Journal: Reviews on Recent Clinical Trials
Volume: 9 Issue: 2 Year: 2014 Page: 115-123
Author(s): Ivan Gentile,Antonio R. Buonomo,Guglielmo Borgia
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 12 Year: 2014 Page: 1391-1404
Author(s): I. Gentile,F. Borgia,N. Coppola,A.R. Buonomo,G. Castaldo,G. Borgia